X
Pharma Advancement
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Articles
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    FDA Accepts BLA for Recommended

    FDA Accepts BLA for Recommended Biosimilar to Simponi

    Merck to Acquire Verona

    Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

    Emerging Oral Small Molecule Drugs

    Emerging Oral Small-Molecule Drugs for Ultra-Rare Diseases

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    FDA Approves Oral Therapy for Treating Hereditary Angioedema

    Avadel Pharmaceuticals Receives

    Avadel Pharmaceuticals Receives Orphan Drug Designation from FDA for LUMRYZ™ (sodium oxybate) for Extended-Release Oral Suspension for the Treatment of Idiopathic Hypersomnia

    Robots and AI in Drug

    Robots and AI in Drug Discovery Are Transforming Medicine

    Stringent Policy around COVID Vaccines Laid by FDA

    Stringent Policy around COVID Vaccines Laid by FDA

    Pharmaceutical-Chemicals Market Booms with Rising API Demand

    Pharmaceutical Chemicals Market Booms with Rising API Demand

    Next in Pharma 2025 Innovations

    Next in Pharma 2025: Innovations Shaping the Future

  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home News

United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers

Content Team by Content Team
4th May 2020
in News, Packaging & Logistic
United Cargo Meets Growing Demand for Pharmaceuticals with New TempControl Containers

Note* - All images used are for editorial and illustrative purposes only and may not originate from the original news provider or associated company.

United Cargo announced it will enhance its TempControl service by becoming the first U.S. carrier to lease temperature-controlled shipping containers manufactured by DoKaSch Temperature Solutions.

The new global rental agreement with DoKaSch enables United Cargo’s TempControl customers to lease the DoKaSch Opticooler RAP directly from United Cargo. With the ability to fit up to five euro pallets or four CP1 Pallets of cargo, the Opticooler helps shippers meet the growing worldwide demand for pharmaceuticals.

“It¿s more important than ever to move critical medical shipments and other temperature-sensitive cargo swiftly and safely to destinations across the globe,” said United Cargo President Jan Krems. “We are proud to be the first North American carrier to sign a direct rental agreement with DoKaSch. This agreement not only offers TempControl customers more options to suit their needs, but allows us to provide an innovative solution to keep critical supply chains moving during the COVID-19 crisis.”

Andreas Seitz, Managing Director at DoKaSch Temperature Solutions, also stresses the relevance of the agreement. “Reliable air cargo options for pharmaceutical products are always in high demand, and this is even more true as the world confronts the COVID-19 pandemic,” Seitz said. “With closed borders and new restrictions every day, a reliable transport infrastructure for highly sensitive pharmaceutical products is crucial. Together with United Cargo, we can help sustain a stable global pharma logistics network.”

DoKaSch Temperature Solutions supplies a fleet of highly reliable temperature-regulated containers. Electrically powered and fully air conditioned, they can heat as well as cool without using dry ice. Batteries allow a continuous operation of the container when grid power is not available — enabling transport of the most valuable and sensitive pharmaceuticals without temperature excursions. Opticoolers may also be used as temporary storage facilities if adequate infrastructure is not available.

TempControl customers seeking more information about leasing DoKaSch Opticooler RAP containers from United Cargo are encouraged to contact their United Cargo Sales Professional.

Previous Post

Astellas Efforts Against the Spread of the Coronavirus Disease (COVID-19)

Next Post

GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development

Related Posts

FDA Accepts BLA for Recommended
FDA Approvals

FDA Accepts BLA for Recommended Biosimilar to Simponi

22nd July 2025
Merck to Acquire Verona
Drug Development

Merck to Acquire Verona Pharma in $10B Deal Boosts COPD Drug

21st July 2025
ChiRhoClin LogiCare3PL Partners for Drug Distribution
News

ChiRhoClin, LogiCare3PL Partners for Drug Distribution

21st July 2025
Thermo Fisher and Sanofi Partners
Manufacturing

Thermo Fisher and Sanofi Partners for US Drug Manufacturing

21st July 2025
EMA Recommendations to Secure Anti D Immunoglobulins Supply
News

EMA Recommendations to Secure Anti-D Immunoglobulins Supply

15th July 2025
FDA Approves Oral Therapy for Treating Hereditary Angioedema
FDA Approvals

FDA Approves Oral Therapy for Treating Hereditary Angioedema

15th July 2025
Next Post
Regeneron and Sanofi Aim a Rheumatoid Arthritis Drug at Coronavirus

GeoVax and Sino Biological Establish Exclusive Supply Agreement for Research Grade Bioreagents Related to SARS-Cov-2 Vaccine Development

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Subscribe Us

System

  • Search
  • Sitemap
  • RSS Feed

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack
  • Newsletters Archive

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Articles
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Insights
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In